Bacteriophages , or phages for short, are "bacteria hunters" that operate with extreme precision: they penetrate exclusively pathogenic microorganisms, replicate within, and subsequently destroy the host without harming healthy tissue or beneficial microflora. This approach opens new horizons in the fight against chronic infections , which remain one of the most challenging problems in modern clinical practice.

Biofilms: A haven for pathogens and a major challenge in treatment

Many pathogens that cause chronic diseases form biofilms —complex, multilayered structures consisting of colonies of harmful microorganisms immersed in a protective matrix created by the microbes themselves. This matrix acts as a kind of "shield" that prevents the penetration of antibiotics, antiseptics, and immune system cells. The very presence of biofilms explains why even long-term and aggressive antibiotic therapy is often ineffective: pathogens within the biofilm reduce their metabolic activity, become almost "invisible" to pharmacological agents, and are able to survive for long periods in a latent state.

It has been confirmed that over 80% of chronic bacterial infections in humans are accompanied by the formation of such structures. They can appear on mucous membranes, in lung tissue, on the surface of the bladder, and also on artificial devices such as catheters, prostheses, and valves.

Under these conditions, traditional antibiotics are minimally effective, and often ineffective altogether. Furthermore, prolonged use of antibacterial agents contributes to the development of resistant strains , complicating treatment. This is where our microscopic ally, the phage, comes to the rescue.

Bacteria vs. Chronic: How Phage Therapy Destroys the Invulnerable

The uniqueness of phages lies not only in their selectivity but also in their ability to overcome biofilm barriers . Upon reaching a vulnerable target, this beneficial virus injects its genetic material into the harmful microbe's cell, replicates within it, and then causes its lysis—literally, a "rupture" releasing new phages that infect adjacent targets. Bacteriophages can synthesize enzymes capable of dissolving the biofilm matrix , opening access to isolated pathogen colonies.

This makes phage therapy a promising alternative or complement to antibiotics, especially in cases where antibacterial drugs prove ineffective. Clinical studies demonstrate the effectiveness of bacterial viruses in treating complex cases, particularly infections associated with prostheses, the respiratory tract, the urinary tract, and the skin.

Diseases that most often become chronic: who is at risk?

Among the diseases that, according to statistics, most often develop into persistent forms , the following dominate:

• Recurrent urinary tract infections
• Chronic bronchitis, bronchiectasis, pneumonia
• Sinusitis, tonsillitis, pharyngitis
• Dermatological purulent lesions
• Infections associated with invasive medical procedures

• Recurrent urinary tract infections
• Chronic bronchitis, bronchiectasis, pneumonia
• Sinusitis, tonsillitis, pharyngitis
• Dermatological purulent lesions
• Infections associated with invasive medical procedures

The culprits of these pathologies are certain types of pathogenic bacteria , in particular:

• Escherichia coli is a leading cause of urinary tract infections.
• Pseudomonas aeruginosa is a gram-negative microorganism that frequently causes infections in patients with cystic fibrosis.
• Staphylococcus aureus , including methicillin-resistant strain (MRSA), is a cause of chronic skin and post-operative lesions.
• Klebsiella pneumoniae - known for severe forms of pneumonia
• Enterococcus faecalis is a frequent guest in complications after catheterization and surgery.

All of them are capable of forming biofilms and producing enzymes that neutralize the effects of antibiotics. Fortunately, bacteriophages have demonstrated the potential to overcome these barriers.

Therapy of the Future: How Phages Are Changing the Rules of the Game

Clinical trials and development of new phage cocktails are ongoing in Europe, the United States, Georgia, and Ukraine. They are used both topically and orally, sometimes in combination with antibiotics for increased effectiveness.

The advantages of this approach include:

• absence of toxicity,
• individual selectivity,
• reduction of antibiotic dependence,
• the ability to destroy biofilms.

Equally important is that, unlike antibiotics, bacteriophages are able to adapt to changes in pathogens , evolving alongside them, which allows them to maintain their effectiveness even in the face of pathogen mutations.

Phage therapy against chronic infections is an example of how biological precision and nature's evolutionary logic can offer a solution where traditional medicine has reached a dead end. In this fight for human health, a good virus becomes a rare ally, working not against us, but for our benefit.